For laboratory research use onlyLocal warehouses · USA / Canada / Australia / Hong Kong
Bulk peptide reorders

Repeat the order.
Review the changes.

A previous order is a useful starting point. A clear reorder brief identifies what should stay the same, what is changing and which decisions need fresh confirmation.

Make the last accepted specification your baseline.

When reordering BPC-157, GHK-Cu, Retatrutide or Semax, include the earlier quote or order reference. Attach the specification actually accepted, rather than an early enquiry or an old product image. List the material identity, stated content per unit, unit count and vial or kit configuration.

Identify the version you want repeated. For private-label supply, add the accepted label, carton and insert revisions. Use the bulk order specification guide if that baseline is incomplete. A product name alone cannot explain which variant you previously approved.

Ask for a clear changed-or-unchanged response.

Repeat peptide order change-review worksheet
FieldPrevious accepted versionNext order response
Material identityFull name, identifier and agreed formSame identity or clearly described difference
Unit contentAccepted amount and reporting basisConfirmed value or proposed revision
PresentationVials or defined kit component listSame configuration or itemised changes
PackagingArtwork filenames and revisionsFiles to reuse and files requiring review
Lot documentsEarlier references kept for historyRecords applicable to the proposed supply
Commercial scopeEarlier quantity and delivery agreementCurrent quote, quantities and dispatch confirmation

Ask for explicit confirmation rather than treating a blank field as unchanged. Keep each peptide and content variant on its own line.

Check the detail behind a familiar name.

For GHK-Cu, retain the copper-complex identity and accepted content basis. For Retatrutide, preserve the agreed material specification instead of substituting another metabolic peptide. A Semax vial order and a defined Semax kit are separate configurations; switching formats needs a revised component list and quotation.

For GLOW, KLOW, Wolverine or Ipamorelin + CJC (no DAC), repeat the complete accepted component specification. Leave unresolved identities, component amounts or totals marked as open questions. Wholesale pack specifications remain subject to enquiry; amounts from another catalogue should not fill gaps in your reorder.

Decide who reviews each change.

Record the proposed difference, reason, affected order lines and person responsible for review. Your laboratory reviewer assesses material or analytical differences; the person approving artwork checks branding files. Purchasing then confirms the revised commercial scope. One email saying "same as before" should not replace those distinct decisions.

ICH Q10 describes evaluation and approval of changes, followed by review after implementation, within its pharmaceutical quality-system model. Read section 3.2.3 of ICH Q10 (PDF). This is background for organised change review, not evidence that our research supply is certified to that model.

Agree when revised files become active.

For an OEM or private-label reorder, identify which order first uses a new logo, label or carton. Ask whether older printed packaging is proposed and keep that decision explicit. Preserve superseded files for reference while clearly identifying the accepted production version.

A packaging change does not automatically mean the material changed. Equally, unchanged artwork does not establish unchanged material or analytical results. Our vial and kit comparison helps describe both presentations without merging their component requirements.

Review the documents for the next supply.

Ask for the offered lot references and matching available analytical documents. Keep earlier reports as history, with the new review recorded separately. The batch traceability guide connects lots and records; the COA checklist helps review report fields. Prior sample approval does not settle every future lot or changed specification.

Make the next quotation easy to review.

Email the previous reference, named variants, accepted specification, requested quantities, vial or kit format and packaging revisions. Identify requested changes and the destination in the USA, Canada or Australia. Ask for current availability, dispatch arrangements and a revised quote where scope differs.

Prepare a repeat-order enquiry

Browse the wholesale catalogue or email sales@wholesalelabpeptides.com.

Your next research order starts here.

Request our current catalogue, wholesale pricing and batch documents.

Let’s talk supply